Oppenheimer Asset Management’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,222
Closed -$255K 1133
2022
Q2
$255K Buy
+8,222
New +$219K ﹤0.01% 1016
2022
Q1
Sell
-3,846
Closed -$228K 1207
2021
Q4
$228K Buy
3,846
+33
+0.9% +$2.28K ﹤0.01% 1152
2021
Q3
$254K Buy
+3,813
New +$235K ﹤0.01% 1087
2020
Q2
Sell
-1,650
Closed -$28K 1153
2020
Q1
$28K Buy
1,650
+734
+80% +$12.9K ﹤0.01% 1345
2019
Q4
$15K Sell
916
-48
-5% -$714 ﹤0.01% 1468
2019
Q3
$16K Buy
964
+223
+30% +$4.47K ﹤0.01% 1473
2019
Q2
$14K Buy
741
+319
+76% +$5.06K ﹤0.01% 1504
2019
Q1
$5K Hold
422
﹤0.01% 1528
2018
Q4
$5K Buy
+422
New +$4.59K ﹤0.01% 1551
2017
Q4
Sell
-6,571
Closed -$65K 1176
2017
Q3
$65K Buy
+6,571
New +$48.3K ﹤0.01% 1304

Other funds holding CYRX

Oppenheimer Asset Management's CYRX Position: Q3 2022 in Review

Oppenheimer Asset Management sold out of CryoPort (CYRX) in Q3 2022, closing a stake of 8,222 shares — an estimated $255K sold.

Oppenheimer Asset Management first reported a position in CYRX in Q3 2017 and held it in 10 quarters. The position peaked at $255K in Q2 2022. 194 funds tracked by Wall St. Rank hold CYRX as of Q3 2022.

  • Oppenheimer Asset Management reported no remaining CryoPort position as of Q3 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 8,222 CryoPort shares in Q3 2022, an estimated $255K.
  • Oppenheimer Asset Management first reported a position in CryoPort in Q3 2017 and held it in 10 quarters.
  • Oppenheimer Asset Management's CryoPort position peaked at $255K in Q2 2022.
  • 194 funds tracked by Wall St. Rank held CryoPort as of Q3 2022.

Based on Oppenheimer Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.